Suchergebnisse - "Voorhees, Peter"

PubPharm (218)

1

Safety and efficacy of belantamab mafodotin with pembrolizumab in patients with relapsed or refractory multiple myeloma

enthalten in: Cancer | 2024

von Suvannasankha, A. | Bahlis, N. | Trudel, S. | +17

2

Health-related quality of life in transplant-eligible patients with newly diagnosed multiple myeloma treated with daratumumab, lenalidomide, bortezomib, and dexamethasone : Patient-reported outcomes from GRIFFIN

enthalten in: American journal of hematology | 2024

von Silbermann, R. | Laubach, J. | Kaufman, J. | +23

3

Real-World Impact of Bridging Therapy on Outcomes of Ide-cel for Myeloma in the U.S. Myeloma Immunotherapy Consortium

enthalten in: ResearchSquare.com | 2024

von Afrough, A. | Hashmi, H. | Hansen, D. | +27

4

Real-world impact of bridging therapy on outcomes of ide-cel for myeloma in the U.S. Myeloma Immunotherapy Consortium

enthalten in: Blood cancer journal | 2024

von Afrough, A. | Hashmi, H. | Hansen, D. | +27

5

Post hoc analysis of daratumumab plus lenalidomide, bortezomib and dexamethasone in Black patients from final data of the GRIFFIN study

enthalten in: British journal of haematology | 2024

von Nooka, A. | Kaufman, J. | Rodriguez, C. | +16

6

Efficacy of Selinexor in Relapsed/Refractory Multiple Myeloma (RRMM) Patients with del17p and Other High-Risk Abnormalities (A Retrospective Single-Center Study)

enthalten in: Life (Basel, Switzerland) | 2024

von Ehsan, H. | Robinson, M. | Voorhees, P. | +8

7

Idecabtagene vicleucel chimeric antigen receptor T-cell therapy for relapsed/refractory multiple myeloma with renal impairment

enthalten in: Haematologica | 2024

von Sidana, S. | Peres, L. | Hashmi, H. | +28

8

Racial and ethnic differences in clinical outcomes among patients with multiple myeloma treated with CAR T-cell therapy

enthalten in: Blood advances | 2024

von Peres, L. | Oswald, L. | Dillard, C. | +31

CommentIn: Blood Adv. 2024 Jan 9;8(1):248-250. - PMID 38194242

9

Community action on FAIR data will fuel a revolution in materials research

enthalten in: MRS bulletin | 2024

von Brinson, L. | Bartolo, L. | Blaiszik, B. | +4

10

Clinical perspectives on the optimal use of lenalidomide plus bortezomib and dexamethasone for the treatment of newly diagnosed multiple myeloma

enthalten in: Haematologica | 2023

von Richardson, P. | Durie, B. | Rosiñol, L. | +15

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[22]